Kuopio, Finland

Janne Mannila




Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2008-2009

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Janne Mannila: Innovator in Cyclodextrin Complexes

Introduction

Janne Mannila is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of cyclodextrin complexes, particularly in relation to cannabinoids. With a total of 2 patents, Mannila's work showcases innovative applications of cyclodextrins in various industries.

Latest Patents

Mannila's latest patents include the following:

1. **Natural Cyclodextrin Complexes** - This invention focuses on the novel use of complexes of cyclodextrin. It specifically involves a complex of a cyclodextrin selected from the group consisting of α-CD, β-CD, and γ-CD, combined with a cannabinoid from the classical cannabinoid group, which includes cannabinol, tetrahydrocannabinol, and cannabidiol.

2. **Methylated Cyclodextrin Complexes** - This patent is directed towards novel complexes of cyclodextrin. It details a complex of a cyclodextrin selected from RM-β-cyclodextrin, DM-β-cyclodextrin, and TM-β-cyclodextrin, along with a cannabinoid from the classical cannabinoid group, including cannabinol, tetrahydrocannabinol, and cannabidiol.

Career Highlights

Mannila is currently associated with Pedipharm Oy, where he continues to develop and innovate in the field of cyclodextrin applications. His work has garnered attention for its potential impact on pharmaceutical formulations and delivery systems.

Collaborations

Mannila collaborates with esteemed colleagues such as Pekka Jarho and Tomi Järvinen, contributing to a dynamic research environment that fosters innovation and development.

Conclusion

Janne Mannila's contributions to the field of cyclodextrin complexes highlight his role as a significant inventor in the industry. His innovative patents reflect a commitment to advancing the applications of cyclodextrins, particularly in relation to cannabinoids.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…